extremely significantp < .01
Administration of lysostaphin resulted in an extremely significant ( p < .01) reduction in S. aureus (0.18 ± 0.25 from 4.57 ± 0.33) and Streptococcus (0.11 ± 0.14 from 3.88 ± 0.29), as well as a significant ( p < .05) reduction in E. coli (0.55 ± 0.42 from 3.11 ± 0.14).